<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04178694</url>
  </required_header>
  <id_info>
    <org_study_id>B.U.N. 143201940980</org_study_id>
    <nct_id>NCT04178694</nct_id>
  </id_info>
  <brief_title>The Influence of Non-invasive Ventilation on Metabolism in Healthy Volunteers</brief_title>
  <acronym>Ganesh</acronym>
  <official_title>The Influence of Non-invasive Ventilation on Metabolism in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Before inclusion in the trial. Careful medical history and medication use will be asked. Once
      included, 5 healthy subjects non-invasive ventilation(V60, Philips, Eindhoven, The
      Netherlands) will be administered at a level of positive end expiratory pressure (PEEP) of 4
      cmH2O and without additional inspiratory support. Inspiratory support will then increase by 2
      cmH2O every 2 minutes until 8 cmH2O is achieved for 2 minutes. The energy expenditure is
      measured using indirect calorimetry (Q-NRG®, Cosmed, Italy). To measure respiratory effort,
      the reversed RPE-scale was created for the purpose of the study. It uses the validated &quot;rate
      of perceived exertion&quot; scale (RPE-scale) which was altered by adding a reversed part. This
      could result in a score of -10 (no respiratory effort) until +10 ( maximal respiratory
      effort) where 0 represents the basal respiratory condition. Monitoring of heart rate, blood
      pressure and cardiac output will be done ( Nexfin®, BMEYE, Amsterdam, The Netherlands).

      After termination of the study clinical observation by principal investigator or
      co-investigator will be done for 15 minutes or until all side effects have worn off. If no
      side effects are observed, subjects will be released.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Energy expenditure</measure>
    <time_frame>during non-invasive ventilation</time_frame>
    <description>in kcal/day Energy expenditure will be measured using indirect calorimetry during different settings of non invasive ventilation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>reversed combined rate of perceived exertion scale</measure>
    <time_frame>during non-invasive ventilation</time_frame>
    <description>no unit, range: [-10 , +10] based on an existing scale of perceived exertion, a reverse part was added to be able to measure an improvement of respiratory exercise compared to normal state.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>respiratory rate</measure>
    <time_frame>during non-invasive ventilation</time_frame>
    <description>in breaths/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>systolic and diastolic bloodpressure</measure>
    <time_frame>during non-invasive ventilation</time_frame>
    <description>in mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cardiac output</measure>
    <time_frame>during non-invasive ventilation</time_frame>
    <description>in liter/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CO2 production of the body ( VCO2)</measure>
    <time_frame>during non-invasive ventilation</time_frame>
    <description>in ml/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>O2 consumption of the body (VO2)</measure>
    <time_frame>during non-invasive ventilation</time_frame>
    <description>in ml/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory quotient</measure>
    <time_frame>during non-invasive ventilation</time_frame>
    <description>no unit</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Energy Expenditure</condition>
  <condition>Non-invasive Ventilation</condition>
  <condition>Metabolism</condition>
  <arm_group>
    <arm_group_label>non-invasive ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects will be submitted to non-invasive ventilation with different settings. During the whole period indirect calorimetry will be performed and haemodynamic parameters will be monitored using a non-invasive device. Reversed combined RPE scale will be asked on a regular base.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>non-invasive ventilation</intervention_name>
    <description>non-invasive ventilation will be performed on every subjects</description>
    <arm_group_label>non-invasive ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy volunteers

        Exclusion Criteria:

          -  pregnancy

          -  prisoners

          -  participation in interventional study in last 2 weeks before enrolment

          -  Current ongoing disease:

          -  Cardiac

          -  respiratory

          -  ear

          -  nose

          -  gastro-intestinal

          -  neurological

          -  psychiatric
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joop Jonckheer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitair Ziekenhuis Brussel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joop Jonckheer, MD</last_name>
    <phone>0032498638164</phone>
    <email>joop.jonckheer@uzbrussel.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elisabeth De Waele, MD, Phd</last_name>
    <email>Elisabeth.dewaele@uzbrussel.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitair ziekenhuis Brussel</name>
      <address>
        <city>Jette</city>
        <state>Brussel</state>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joop Jonckheer</last_name>
      <phone>0498638164</phone>
      <email>joop.jonckheer@uzbrussel.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>November 7, 2019</study_first_submitted>
  <study_first_submitted_qc>November 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2019</study_first_posted>
  <last_update_submitted>April 30, 2020</last_update_submitted>
  <last_update_submitted_qc>April 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

